PubRank

D L Mann

Author PubWeight™ 275.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996 10.49
2 Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992 5.25
3 Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet 1984 4.68
4 A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989 4.04
5 Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med 1980 3.81
6 Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996 3.47
7 Epidermal Langerhans cells--a target for HTLV-III/LAV infection. J Invest Dermatol 1987 3.41
8 Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001 3.15
9 Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 1981 3.02
10 Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci U S A 1981 2.86
11 Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998 2.77
12 Structure of HLA antigens: amino-acid and carbohydrate compositions and NH2-terminal sequences of four antigen preparations. Proc Natl Acad Sci U S A 1976 2.71
13 Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation 1999 2.68
14 Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 1999 2.59
15 Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation. J Immunol 1981 2.30
16 Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A 2000 2.25
17 B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med 1978 2.11
18 Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996 2.10
19 Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993 1.94
20 Genetic differences between primary and secondary sicca syndrome. N Engl J Med 1979 1.93
21 Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 2004 1.86
22 Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001 1.81
23 Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans. Proc Natl Acad Sci U S A 1980 1.81
24 Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 1989 1.80
25 Detection of antigens specific for B-lymphoid cultured cell lines with human alloantisera. J Exp Med 1975 1.76
26 Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigen. J Exp Med 1976 1.74
27 Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci U S A 1989 1.73
28 Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 1999 1.70
29 HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol 1987 1.69
30 Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. Hum Immunol 2001 1.68
31 Purification of papain-solubilized histocompatibility antigens from a cultured human lymphoblastoid line, RPMI 4265. J Biol Chem 1975 1.66
32 Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol 1995 1.63
33 Genetic basis of gluten-sentitive enteropathy. Gastroenterology 1978 1.60
34 Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA 1987 1.60
35 The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. Am Rev Respir Dis 1989 1.57
36 Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001 1.56
37 Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995 1.55
38 Amyl nitrite may alter T lymphocytes in homosexual men. Lancet 1982 1.54
39 Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci U S A 1985 1.54
40 In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J Infect Dis 2001 1.53
41 Tumor necrosis factor and viral myocarditis: the fine line between innate and inappropriate immune responses in the heart. Circulation 2001 1.52
42 Human lymphocyte membrane (HL-A) alloantigens: isolation, purification and properties. J Immunol 1969 1.50
43 Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation 2001 1.50
44 Immunofluorescent detection of human B cell alloantigens on S-Ig-positive lymphocytes and epidermal Langerhans cells. J Immunol 1978 1.47
45 Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J Natl Cancer Inst 1995 1.46
46 Origin of the HIV-susceptible human CD4+ cell line H9. AIDS Res Hum Retroviruses 1989 1.45
47 Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 2000 1.45
48 Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 1997 1.41
49 Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 1996 1.40
50 Normalization of cardiac structure and function after regression of cardiac hypertrophy. Am Heart J 1994 1.39
51 Detergent solubilization, purification, and separation of specificities of HLA antigens from a cultured human lymphoblastoid line, RPMI 4265. J Biol Chem 1977 1.38
52 Decreased helper T lymphocytes in homosexual men. I. Sexual contact in high-incidence areas for the acquired immunodeficiency syndrome. Am J Epidemiol 1985 1.37
53 Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. J Immunol 1982 1.34
54 Langerhans' cells are an actual site of HIV-1 replication. Intervirology 1988 1.27
55 Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 1997 1.27
56 Differential expression of heat shock proteins in normal and failing human hearts. J Mol Cell Cardiol 1998 1.27
57 Detection of an antigen associated with acute leukemia. Science 1971 1.26
58 Seminal fluid excretion of cytomegalovirus related to immunosuppression in homosexual men. Br Med J (Clin Res Ed) 1983 1.26
59 HTLV-I--associated B-cell CLL: indirect role for retrovirus in leukemogenesis. Science 1987 1.25
60 Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection. Proc Natl Acad Sci U S A 1997 1.25
61 Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association. J Biol Chem 1977 1.24
62 Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995 1.24
63 Inhibitory activity of antibodies to human Ia-like determinants: comparison of intact and pepsin-digested antibodies. J Immunol 1983 1.23
64 Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. J Biol Chem 1997 1.23
65 Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex. J Clin Invest 1980 1.21
66 Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 1999 1.17
67 HLA-A2 and type 2 (insulin independent) diabetes mellitus in Pima Indians: an association of allele frequency with age. Diabetologia 1981 1.16
68 Solubilization of human leucocyte membrane isoantigens. Nature 1968 1.16
69 Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte. Circulation 1998 1.16
70 Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc Natl Acad Sci U S A 1988 1.15
71 HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res Hum Retroviruses 1994 1.15
72 HLA-DR antibodies and HTLV-III antibody ELISA testing. Lancet 1985 1.14
73 Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. Circulation 1998 1.14
74 Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis 1989 1.13
75 Methylation of human T-cell leukemia virus proviral DNA and viral RNA expression in short- and long-term cultures of infected cells. Virology 1984 1.13
76 Th17/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitis. Br J Dermatol 2009 1.11
77 The effect of enzyme inhibitors on the solubilization of HL-A antigens with 3 M KCl. Transplantation 1972 1.11
78 Second genetic locus in the HLA region for human B-cell alloantigens. Nature 1976 1.11
79 Derivative fluorescence spectral analysis of polycyclic aromatic hydrocarbon-DNA adducts in human placenta. Chem Res Toxicol 1992 1.10
80 Low T-lymphocyte ratios in homosexual men. Epidemiologic evidence for a transmissible agent. JAMA 1984 1.10
81 Participation of suppressor T cells in the immunosuppressive activity of a heteroantiserum to human Ia-like antigens (p23,30). J Exp Med 1980 1.09
82 Brief murine myocardial I/R induces chemokines in a TNF-alpha-independent manner: role of oxygen radicals. Am J Physiol Heart Circ Physiol 2001 1.09
83 Cell lines producing human T-cell lymphoma virus show altered HLA expression. Nature 1983 1.09
84 Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus. J Exp Med 1983 1.09
85 SR compartment calcium and cell apoptosis in SERCA overexpression. Cell Calcium 2000 1.08
86 Specific B-cell antigens associated with gluten-sensitive enteropathy and dermatitis herpetiformis. Lancet 1976 1.08
87 Circulating interleukin-6 in severe heart failure. Am J Cardiol 1997 1.07
88 Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma. Hepatology 1996 1.07
89 Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro. Am J Physiol 1995 1.05
90 Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais. J Infect Dis 1998 1.04
91 Contractile function of isolated feline cardiocytes in response to viscous loading. Am J Physiol 1989 1.04
92 An acute-leukemia antigen: correlation with clinical status. N Engl J Med 1972 1.04
93 Complete amino acid sequence of a papain-solubilized human histocompatibility antigen HLA-B7. 1. Isolation and amino acid composition of fragments and of tryptic and chymotryptic peptides. Biochemistry 1979 1.03
94 Endemic Kaposi's sarcoma in human immunodeficiency virus type 1-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol 1990 1.03
95 Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation. Circ Res 1992 1.02
96 Association between Takayasu's arteritis and a B-cell alloantigen in North Americans. N Engl J Med 1982 1.02
97 Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. AIDS Res Hum Retroviruses 1998 1.01
98 Comparison of soluble human and mouse transplantation antigens. Proc Natl Acad Sci U S A 1969 1.01
99 Chemical and immunological characterization of HL-A linked B-lymphocyte alloantigens. Cold Spring Harb Symp Quant Biol 1977 1.01
100 Temporary inhibition of antibody-dependent, cell-mediated cytotoxicity by pretreatment of human attacking cells with ammonium chloride. J Immunol 1976 1.01
101 The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2000 1.00
102 Tumor necrosis factor-alpha-induced expression of heat shock protein 72 in adult feline cardiac myocytes. Am J Physiol 1996 1.00
103 Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circ Res 1995 1.00
104 Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol 2000 1.00
105 Group B Streptococcus induces TNF-alpha gene expression and activation of the transcription factors NF-kappa B and activator protein-1 in human cord blood monocytes. J Immunol 2000 0.99
106 Human lymphocyte antigens characterizing psoriatic arthritis and its subtypes. J Rheumatol 1983 0.99
107 Association of rare alleles of the Harvey ras protooncogene locus with lung cancer. Cancer Res 1990 0.99
108 Distribution of alloantigens on human Fc receptor-bearing lymphocytes: the presence of B cell alloantigens on sIg-positive but not sIg-negative lymphocytes. J Immunol 1977 0.99
109 Cell surface antigen expression in newborn cord blood lymphocytes infected with HTLV. J Immunol 1983 0.98
110 Sharing Ia antigens between species. III. Ia specificities shared between mice and human beings. Scand J Immunol 1979 0.98
111 Structure of HL-A A and B antigens isolated from cultured human lymphocytes. Cold Spring Harb Symp Quant Biol 1977 0.98
112 T cell subsets in healthy black smokers and nonsmokers. Evidence for ethnic group as an important response modifier. Am Rev Respir Dis 1991 0.97
113 Evidence that antisera that react with products of the human HLA-DR locus may block in vitro antigen-induced proliferation by inducing suppression. J Immunol 1982 0.97
114 Load induction of cardiac hypertrophy. J Mol Cell Cardiol 1989 0.97
115 Blocking the endogenous increase in HSP 72 increases susceptibility to hypoxia and reoxygenation in isolated adult feline cardiocytes. Circulation 1997 0.97
116 Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1986 0.96
117 Erythropoietin assay and ferrokinetic measurements in anemic uremic patients. JAMA 1965 0.96
118 Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. Ann Intern Med 1982 0.95
119 Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart. Circulation 2001 0.94
120 T-cell subsets in healthy teenagers: transition to the adult phenotype. Clin Immunol Immunopathol 1990 0.94
121 The immune reactivity of heterologous antisera against a solubilized human lymphoid membrane component. Tissue Antigens 1971 0.94
122 Human lymphocyte-dependent antibody mediated cytotoxicity and direct lymphocyte cytotoxicity against non-HL-A antigens. Nature 1974 0.93
123 Generation of CD4(+) and CD8(+) T lymphocyte responses by dendritic cells armed with PSA/anti-PSA (antigen/antibody) complexes. Clin Immunol 2001 0.93
124 Configuration and expression of the T cell receptor beta chain gene in human T-lymphotrophic virus I-infected cells. J Exp Med 1986 0.93
125 Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemia. J Clin Invest 1984 0.93
126 The role of cytokines in the failing human heart. Cardiol Clin 1998 0.93
127 Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis. J Exp Med 1982 0.92
128 Haplotypic variation of the transporter associated with antigen processing (TAP) genes and their extension of HLA class II region haplotypes. Immunogenetics 1993 0.92
129 Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Circulation 2001 0.92
130 Specific human B lymphocyte alloantigens linked to HL-A. Proc Natl Acad Sci U S A 1975 0.91
131 Cryopreservation and long-term liquid nitrogen storage of peripheral blood mononuclear cells for flow cytometry analysis: effects on cell subset proportions and fluorescence intensity. J Clin Lab Anal 1991 0.91
132 Nitric oxide provokes tumor necrosis factor-alpha expression in adult feline myocardium through a cGMP-dependent pathway. Circulation 2000 0.91
133 Type 1 human T-cell leukemia virus small envelope protein expressed in mouse cells by using a bovine papilloma virus-derived shuttle vector. Mol Cell Biol 1985 0.90
134 Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies. AIDS 1995 0.90
135 Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cells. J Immunol 1973 0.90
136 Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading. Circulation 2001 0.90
137 The role of the major histocompatibility complex in human immunodeficiency virus infection--ever more complex? J Infect Dis 1994 0.90
138 Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells. J Exp Med 1991 0.90
139 HLA DR alloantigens in different subsets of patients with Sjögren's syndrome and in family members. Ann Rheum Dis 1983 0.90
140 Serologic and structural studies of DR-related antigens. Transplant Proc 1979 0.89
141 B lymphocyte antigens in sicca syndrome. Science 1978 0.89
142 Fluorescence and mass spectral evidence for the formation of benzo[a]pyrene anti-diol-epoxide-DNA and -hemoglobin adducts in humans. Carcinogenesis 1989 0.88
143 Decreased helper T lymphocytes in homosexual men. II. Sexual practices. Am J Epidemiol 1985 0.88
144 Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. J Heart Lung Transplant 2000 0.88
145 Alkyl and aryl carcinogen adducts detected in human peripheral lung. Carcinogenesis 1989 0.88
146 Tarsal coalition: a review of the literature and presentation of 13 cases. Foot Ankle 1988 0.88
147 Human cell-surface structures related to Haemophilus influenzae type B disease. Lancet 1971 0.87
148 Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. Circulation 1998 0.87
149 Ankylosing spondylitis and systemic lupus erythematosus: a rare HLA combination. Arch Intern Med 1982 0.87
150 Left ventricular assist devices and the failing heart: a bridge to recovery, a permanent assist device, or a bridge too far? Circulation 1998 0.86
151 A novel bile duct cannulation method with tail cuff exteriorization allowing continuous intravenous infusion and enterohepatic recirculation in the unrestrained rat. Lab Anim 2001 0.86
152 Cytokines as emerging targets in the treatment of heart failure. Trends Cardiovasc Med 2000 0.86
153 Selective extraction and quantitative analysis of non-starch and starch lipids from wheat flour. J Sci Food Agric 1975 0.86
154 Cytotoxic antibody for epithelial cells in human graft versus host disease. Nature 1971 0.86
155 Histocompatibility antigens. Annu Rev Microbiol 1971 0.86
156 Tumor necrosis factor-alpha and the failing human heart. Clin Cardiol 1995 0.86
157 Biochemical and molecular epidemiology of human cancer: indicators of carcinogen exposure, DNA damage, and genetic predisposition. Environ Health Perspect 1987 0.86
158 Molecular heterogeneity of human lymphoid (HL-A) alloantigens. Science 1969 0.86
159 An overview of tumor necrosis factor alpha and the failing human heart. Curr Opin Cardiol 1999 0.85
160 Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial. Chest 2001 0.85
161 A human alloantiserum precipitates Ia-like molecules from chronic lymphocytic leukemia cells. J Immunol 1977 0.85
162 Thymosin alpha 1 levels and helper:suppressor ratios in homosexual men. N Engl J Med 1983 0.85
163 The role of cytokines in disease progression in heart failure. Curr Opin Cardiol 1997 0.85
164 DNA methylation and expression of HLA-DR alpha. Mol Cell Biol 1984 0.84
165 Use of targeted anticytokine treatments in heart failure. Circulation 2000 0.84
166 Type C retroviruses of the human T cell leukemia family are not evident in patients with systemic lupus erythematosus. Arthritis Rheum 1986 0.84
167 Pitfalls in measuring cytokines. Ann Intern Med 1994 0.84
168 Cardiac remodeling as a consequence and cause of progressive heart failure. Clin Cardiol 1998 0.84
169 HTLV-I infection of T and B cells of a patient with adult T-cell leukemia-lymphoma (ATLL) and transmission of HTLV-I from B cells to normal T cells. Leuk Res 1985 0.84
170 Immunogenic properties of papain-solubilized H-2 alloantigens. Transplantation 1970 0.84
171 Familial chronic lymphocytic leukemia. J Natl Cancer Inst 1983 0.84
172 Genetic control of B-cell alloantigens: evidence for gene(s) linked to the HLA-A locus. Tissue Antigens 1978 0.84
173 Cytokines in heart failure: pathogenetic mechanisms and potential treatment. Proc Assoc Am Physicians 1999 0.84
174 Synchronous fluorescence spectroscopic, immunoaffinity chromatographic and 32P-postlabeling analysis of human placental DNA known to contain benzo[a]pyrene diol epoxide adducts. Carcinogenesis 1990 0.83
175 Identification of lymphocyte-dependent antibody in sera from multiply transfused patients. Transplantation 1974 0.83
176 Histocompatibility antigen combinations in rheumatoid arthritis. Clin Exp Rheumatol 1985 0.83
177 Immunogenetic determinants of familial acute lymphocytic leukemia. Ann Intern Med 1978 0.83
178 HLA-DRw alloantigens can be detected on peripheral blood T lymphocytes. J Immunol 1980 0.83
179 Detection and characterization of human serum antibodies to polycyclic aromatic hydrocarbon diol-epoxide DNA adducts. J Clin Invest 1988 0.83
180 Acute myelocytic leukaemia and leukaemia-associated antigens in sisters. Lancet 1975 0.82
181 Susceptibility to Reiter's syndrome is associated with alleles of TAP genes. Arthritis Rheum 1995 0.82
182 Prolonged survival of tumor allografts in mice pretreated with soluble transplantation antigens. J Natl Cancer Inst 1973 0.82
183 Properties of HL-A alloantigens solubilized by chemical techniques. Transplant Proc 1971 0.82
184 Differential methylation of class I histocompatibility antigen genes in T-cell lines derived from two different types of T-cell malignancies. Leuk Res 1984 0.82
185 Heterologous antisera against specific HL-A antigens. Transplantation 1971 0.82
186 Waldenström's macroglobulinemia and autoimmune disease in a family. Ann Intern Med 1980 0.82
187 Crossreactive antigens on human cells infected with Rauscher leukemia virus and on human acute leukemia cells. Proc Natl Acad Sci U S A 1973 0.81
188 Cardiocyte contractile performance in experimental biventricular volume-overload hypertrophy. Am J Physiol 1993 0.81
189 Monocyte function in mixed lymphocyte reactions. Cell Immunol 1980 0.81
190 In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex. J Clin Invest 1983 0.81
191 B-cell alloantigens on T lymphocytes. Transplant Proc 1979 0.81
192 An evaluation of the significance of amino acid sequence homologies in human histocompatibility antigens (HLA-A and HLA-B) with immunoglobulins and other proteins, using relatively short sequences. Scand J Immunol 1980 0.80
193 Human antisera detecting leukemia-associated antigens on autochthonous tumor cells. J Natl Cancer Inst 1975 0.80
194 Specific MLC stimulation by cultured B cells. Tissue Antigens 1976 0.80
195 Interferon regulation of DR antigen expression and alloantigen-presenting capabilities of the promyelocytic cell line HL60. Scand J Immunol 1985 0.80
196 Langerhans cells in HIV-1 infection. J Am Acad Dermatol 1990 0.79
197 Dynamic regulation of the extracellular matrix after mechanical unloading of the failing human heart: recovering the missing link in left ventricular remodeling. Circulation 2001 0.79
198 Adaptive chaos and AIDS. Curr Biol 1992 0.79
199 Autoimmunity, immunoglobulin adsorption and dilated cardiomyopathy: has the time come for randomized clinical trials? J Am Coll Cardiol 2001 0.79
200 Human T-cell leukemia/lymphoma virus I and/or Epstein-Barr virus-infected B-cell lines spontaneously produce acid-labile alpha-interferon. J Clin Immunol 1985 0.79
201 Acute leukemia-associated antigens. Cancer 1974 0.79
202 Single- versus dual-chamber sensor-driven pacing: comparison of cardiac outputs. Am Heart J 1991 0.79
203 raf protooncogene expression in neural and immune tissues. Adv Biochem Psychopharmacol 1988 0.79
204 Signals for cardiac muscle hypertrophy in hypertension. J Cardiovasc Pharmacol 1991 0.78
205 Biochemical properties of papain-solubilized murine and human histocompatibility alloantigens. Fed Proc 1971 0.78
206 Molecular mechanics and antibody binding in the structural analysis of polycyclic aromatic hydrocarbon-diol-epoxide--DNA adducts. Carcinogenesis 1990 0.78
207 Human lymphocyte dependent antibody mediated cytotoxicity: adherence of lymphocytes to antibody treated target cells. Cell Immunol 1975 0.78
208 Dialysis-induced alterations in left ventricular filling: mechanisms and clinical significance. Am J Kidney Dis 1991 0.78
209 Sports injuries in the emergency department: controversies and management guidelines. Can Fam Physician 1988 0.78
210 Interleukin-6 and viral myocarditis: the Yin-Yang of cardiac innate immune responses. J Mol Cell Cardiol 2001 0.78
211 Solubilization, properties and molecular separation of HL-A alloantigens. Transplant Proc 1969 0.78
212 Characterization of LMP polymorphism in homozygous typing cells and a random population. Hum Immunol 1999 0.77
213 Biochemical and molecular epidemiology of human cancer risk. Monogr Pathol 1985 0.77
214 Family studies of B lymphocyte alloantigens in systemic lupus erythematosus. J Rheumatol 1982 0.77
215 Left ventricular volume during supine exercise: importance of myocardial scar in patients with coronary heart disease. J Am Coll Cardiol 1987 0.77
216 Molecular and immunologic analysis of a chronic lymphocytic leukemia case with antibodies against human T-cell leukemia virus. Cancer 1985 0.77
217 Effects of age on ventricular performance during graded supine exercise. Am Heart J 1986 0.76
218 Absence of cardioversion-induced ventricular arrhythmias in patients with therapeutic digoxin levels. J Am Coll Cardiol 1985 0.76
219 DNA restriction fragment length polymorphisms at either end of the c-raf-1 locus at 3p25. Oncogene Res 1988 0.76
220 Immune T cells reactive against human T-cell leukaemia/lymphoma virus. Lancet 1984 0.76
221 Serological characterization of polycyclic aromatic hydrocarbon diolepoxide-DNA adducts using monoclonal antibodies. Carcinogenesis 1990 0.76
222 Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy. J Biotechnol 1999 0.76
223 Is inflammation good for the ischemic heart--perspectives beyond the ordinary. Z Kardiol 2000 0.76
224 Erythrocytosis and primary aldosteronism. Ann Intern Med 1967 0.76
225 The pharmacokinetics of etanercept in patients with heart failure. Br J Clin Pharmacol 2001 0.75
226 How should we measure cytokines in heart failure? Circulation 1996 0.75
227 Lymphoma-specific T- and B-cell responses suggest the involvement of HTLV-I in virus-non-productive lymphomas of a married couple. Int J Cancer 1988 0.75
228 Relationship of renal mass to erythropoietin production. Lab Invest 1968 0.75
229 Relationship of functional recovery to scar contraction after myocardial infarction in the canine left ventricle. Am Heart J 1989 0.75
230 Heterogeneity of acute lymphocytic leukemia cell surface markers as detected by monoclonal antibodies. J Natl Cancer Inst 1983 0.75
231 Sensitization to water-soluble HL-A antigens. Transplant Proc 1971 0.75
232 Lipids in wheat flour doughs. J Sci Food Agric 1973 0.75
233 Antiserum to a soluble lymphoid membrane preparation stimulates human leukocyte DNA synthesis. J Immunol 1971 0.75
234 Frozen-thawed mononuclear cells as a source of B lymphocytes for antibody screening. Tissue Antigens 1977 0.75
235 Separation of complement-dependent and lymphocyte-dependent cytotoxic activity in human sera. Eur J Immunol 1975 0.75
236 Voluntary intake, gain, digestibility, rate of passage and gastrointestinal tract fill in tropical and temperate breeds of sheep. J Anim Sci 1987 0.75
237 Reversion of mitral valve preclosure in acute aortic insufficiency secondary to infective endocarditis. Chest 1989 0.75
238 Lack of association of human "B cell" antigens and Fc receptor activity of antibody-dependent cytotoxic lymphocytes. J Immunol 1976 0.75
239 Prolonged skin allograft survival in mice pretreated with soluble transplantation antigens. Transplantation 1971 0.75
240 Catheter-induced tricuspid regurgitation. Incidence and clinical significance. Chest 1991 0.75
241 Studies on the contact sensitization of man with simple chemicals: V. Clonal priming allows direct in vitro assessment of autologous HLA-associated factors required for immune response to dinitrochlorobenzene. J Invest Dermatol 1979 0.75
242 Doppler and two-dimensional echocardiographic diagnosis of Björk-Shiley prosthetic valve malfunction: importance of interventricular septal motion and the timing of onset of valve flow. J Am Coll Cardiol 1986 0.75
243 Studies on the immunologic reactivity of sera from acute leukemia patients. Prog Exp Tumor Res 1974 0.75
244 High risk of sacroiliitis in HLA--B27-positive Pima Indian men. Arthritis Rheum 1982 0.75
245 Awards and named lecturers at the American Heart Association 71st scientific sessions. Circulation 1999 0.75
246 Anesthetic management of a pregnant patient with the hyperimmunoglobulin E (Job's) syndrome. Anesth Analg 1990 0.75
247 Comparison of HIV-1 envelope-specific CD4+ T cell lines simultaneously established from peripheral blood mononuclear cells and lymph node biopsy in HIV-1-infected individuals. J Immunol 1997 0.75
248 Effects of rapid weight gain to puberty on reproduction, mammary development and lactation in ewe lambs. Theriogenology 1989 0.75
249 Experimental options in the treatment of heart failure: the role of cytokine antagonism. Heart Fail Monit 2001 0.75
250 Cross-sectional echocardiographic assessment of regional left ventricular performance and myocardial perfusion. Prog Cardiovasc Dis 1986 0.75
251 Effects of slaframine on circulating concentrations of growth hormone and glucose. Poult Sci 1987 0.75
252 Human lymphocyte alloantigens: genetic control and relation to disease. Clin Haematol 1977 0.75
253 HLA and B-lymphocyte alloantigens in Gila River Indians. Tissue Antigens 1983 0.75
254 Effect of renin, angiotensin II and aldosterone on erythropoiesis. Proc Soc Exp Biol Med 1966 0.75
255 Inhibition of DRw antisera reactivity by mono and oligosaccharides. J Immunol 1980 0.75
256 Veterans Affairs Quality Enhancement Research Initiative in chronic heart failure. Med Care 2000 0.75
257 Effects of chronic mitral regurgitation on diastolic function in isolated cardiocytes. Circ Res 1993 0.75
258 HLA alloantigens: disease association and biologic significance. Semin Hematol 1979 0.75
259 Is there room for the heart in CHEST? Chest 1995 0.75
260 A clinical trial of chemotherapy and RAJI immunotherapy in advanced acute lymphatic leukemia. Cancer Res 1975 0.75
261 Serological characterization of human T-cell leukemia (lymphotropic) virus, type I (HTLV-I) small envelope protein. Virology 1986 0.75
262 Dosimeters of human exposure to carcinogens: polycyclic aromatic hydrocarbon-macromolecular adducts. IARC Sci Publ 1988 0.75
263 Human B-cell antigens in acute lymphocytic leukemia. Lack of correlation with other lymphocyte surface markers. J Natl Cancer Inst 1979 0.75